Literature DB >> 7812024

Kaposi's sarcoma and AIDS in Uganda: its frequency and gastrointestinal distribution.

M Ravera1, A Reggiori, E Cocozza, M Andreata, F Ciantia.   

Abstract

The frequency and distribution of gastrointestinal Kaposi's sarcoma were investigated in 63 consecutive AIDS patients. The main risk factor for AIDS was heterosexual intercourse. Gastrointestinal lesions were found in 24 cases (38.1%): 12 patients (11.1%) had both upper and lower GI tract involvement, 7 patients (11.1%) had only oesophago-gastroduodenal lesions and 5 (7.9%) only lower tract disease. Our results show that in heterosexual Africans, the tumours closely resemble the tumours of western homosexuals in endoscopic appearance, in being multicentric and in the gastro-intestinal tract involved. We conclude that even in the heterosexual African AIDS population, the gastrointestinal tract is frequently involved and this phenomenon, if more widely studied might give us new elements about the aetiophatogenesis of Kaposi's sarcoma which is still unclear.

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Africa; Africa South Of The Sahara; Behavior; Biology; Cancer; Developing Countries; Diseases; Eastern Africa; English Speaking Africa; Gastrointestinal Effects; Heterosexuals; Hiv Infections; Homosexuals; Neoplasms; Physiology; Research Report; Sex Behavior; Uganda; Viral Diseases

Mesh:

Year:  1994        PMID: 7812024

Source DB:  PubMed          Journal:  Ital J Gastroenterol        ISSN: 0392-0623


  2 in total

1.  Paediatric intussusception caused by acquired immunodeficiency syndrome-associated Kaposi sarcoma.

Authors:  Pratistadevi K Ramdial; Yetish Sing; G P Hadley; Nivesh A Chotey; Mabitsela S Mahlakwane; Bhugwan Singh
Journal:  Pediatr Surg Int       Date:  2010-06-10       Impact factor: 1.827

2.  Severe gastrointestinal haemorrhage due to primary intestinal kaposi's sarcoma - a case report.

Authors:  Abdulkadir A Salako; Adewale O Adisa; Olusegun S Ojo; Anthony O Arigbabu
Journal:  Indian J Surg       Date:  2008-07-30       Impact factor: 0.656

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.